CALIFORNIA: Medical Marijuana Inc. Holdings Announces Commencement of Clinical Trials for New Pharmaceutical Product
San Diego, CA (eTeligis via ACCESSWIRE) 7/30/2013 – Medical Marijuana Inc. (OTC PINK: MJNA) and CanChew Biotechnologiesare pleased to inform shareholders and the general public that the CanChew Biotechnologies Board of Directors elected three new executives with clearly defined roles Dr. George E. Anastassov, MD, DDS, Exec. MBA as Chief Executive Officer (CEO); Dr. Philip. A. Van Damme DMD, MD, PhD as Chief Medical Officer (CMO); and Lekhram Changoer, MSc BSc as Chief Technology Officer (CTO)during their annual meeting last week at the Medical Marijuana Inc. offices in San Diego, California.
“These gentlemen have been with CanChew Biotechnologies since its inception. We are very excited to take our business partnership to new heights with these appointments,” said Charles Vest, Director of Communications for HempMedsPX, the marketing company for Medical Marijuana Inc. and all MJNA portfolio companies.